Drugs Approved for Esophageal Cancer
This page lists cancer drugs approved by the Food and Drug Administration (FDA) for esophageal cancer, including gastroesophageal junction cancer. The list includes generic names and brand names. The drug names link to NCI's Cancer Drug Information summaries. There may be drugs used in esophageal cancer that are not listed here.
Drugs Approved for Esophageal Cancer
Drug Combinations Used in Esophageal Cancer
Drugs Approved for Gastroesophageal Junction Cancer
- Capecitabine
- Cyramza (Ramucirumab)
- Docetaxel
- Enhertu (Fam-Trastuzumab Deruxtecan-nxki)
- Fam-Trastuzumab Deruxtecan-nxki
- Herceptin (Trastuzumab)
- Keytruda (Pembrolizumab)
- Lonsurf (Trifluridine and Tipiracil Hydrochloride)
- Nivolumab
- Nivolumab and Hyaluronidase-nvhy
- Opdivo (Nivolumab)
- Opdivo Qvantig (Nivolumab and Hyaluronidase-nvhy)
- Pembrolizumab
- Ramucirumab
- Taxotere (Docetaxel)
- Tevimbra (Tislelizumab-jsgr)
- Tislelizumab-jsgr
- Trastuzumab
- Trifluridine and Tipiracil Hydrochloride
- Vyloy (Zolbetuximab-clzb)
- Xeloda (Capecitabine)
- Zolbetuximab-clzb